Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Apyx Medical Corp (APYX)

Apyx Medical Corp (APYX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 121,275
  • Shares Outstanding, K 34,453
  • Annual Sales, $ 48,520 K
  • Annual Income, $ -15,170 K
  • 60-Month Beta 1.17
  • Price/Sales 2.42
  • Price/Cash Flow N/A
  • Price/Book 2.36
Trade APYX with:

Options Overview Details

View History
  • Implied Volatility 86.48% ( +10.13%)
  • Historical Volatility 74.77%
  • IV Percentile 85%
  • IV Rank 11.23%
  • IV High 533.12% on 05/11/22
  • IV Low 29.95% on 12/22/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 1
  • Put/Call OI Ratio 0.36
  • Today's Open Interest 76
  • Open Int (30-Day) 155

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.20
  • Number of Estimates 1
  • High Estimate -0.20
  • Low Estimate -0.20
  • Prior Year -0.12
  • Growth Rate Est. (year over year) -66.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.01 +15.61%
on 05/11/22
4.98 -30.11%
on 04/27/22
-1.22 (-25.96%)
since 04/22/22
3-Month
3.01 +15.61%
on 05/11/22
11.19 -68.90%
on 03/01/22
-6.18 (-63.98%)
since 02/23/22
52-Week
3.01 +15.61%
on 05/11/22
17.50 -80.11%
on 11/22/21
-6.88 (-66.41%)
since 05/21/21

Most Recent Stories

More News
Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of -30.77% and 7.70%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

APYX : 3.48 (-1.14%)
CGC : 5.19 (-5.98%)
Apyx Medical Corporation Reports First Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® and J-Plasma® in surgical...

APYX : 3.48 (-1.14%)
Quidel (QDEL) Q1 Earnings and Revenues Top Estimates

Quidel (QDEL) delivered earnings and revenue surprises of 25.65% and 21.77%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

QDEL : 101.25 (+1.34%)
APYX : 3.48 (-1.14%)
LeMaitre Vascular (LMAT) Q1 Earnings Miss Estimates

LeMaitre (LMAT) delivered earnings and revenue surprises of -3.57% and 1.84%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

LMAT : 44.33 (-1.05%)
APYX : 3.48 (-1.14%)
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of Apyx Medical Corporation (“Apyx” or the “Company”) (NASDAQ: APYX...

APYX : 3.48 (-1.14%)
The Law Offices of Frank R. Cruz Continues Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors

The Law Offices of Frank R. Cruz continues its investigation of Apyx Medical Corporation (“Apyx” or the “Company”) (NASDAQ: APYX ) on behalf of investors concerning the Company’s possible violations...

APYX : 3.48 (-1.14%)
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors

Law Offices of Howard G. Smith continues its investigation on behalf of Apyx Medical Corporation (“Apyx” or the “Company”) (NASDAQ: APYX ) investors concerning the Company’s possible violations...

APYX : 3.48 (-1.14%)
APYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Apyx Medical Corp. on Behalf of Apyx Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Apyx Medical Corp. (“Apyx” or the “Company”) (NASDAQ: APYX) on behalf...

APYX : 3.48 (-1.14%)
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors

Law Offices of Howard G. Smith announces an investigation on behalf of Apyx Medical Corporation (“Apyx” or the “Company”) (NASDAQ: APYX ) investors concerning the Company’s possible violations...

APYX : 3.48 (-1.14%)
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Apyx Medical Corporation (“Apyx” or the...

APYX : 3.48 (-1.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Apyx Medical Corporation is an energy technology company. It provides products in the cosmetic and surgical markets. The company's Helium Plasma Technology is marketed and sold as Renuvion(R) in the cosmetic surgery market and J-Plasma(R) in the hospital surgical market. Apyx Medical Corporation, formerly...

See More

Key Turning Points

3rd Resistance Point 3.74
2nd Resistance Point 3.65
1st Resistance Point 3.57
Last Price 3.48
1st Support Level 3.40
2nd Support Level 3.31
3rd Support Level 3.23

See More

52-Week High 17.50
Fibonacci 61.8% 11.96
Fibonacci 50% 10.26
Fibonacci 38.2% 8.55
Last Price 3.48
52-Week Low 3.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar